Family · Pharmaceutical analytical standards
Imidafenacin
An antimuscarinic for overactive bladder discovered and developed in Japan, where it was approved in 2007 for urgency, increased urinary frequency and urge incontinence. This family brings together the active ingredient, labelled standards and other impurities.
Did you know?It mainly blocks the M3 and M1 muscarinic receptors and was designed to act selectively on the bladder, with the aim of reducing the dry mouth typical of this class of medicines.
No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
